Stage IA Cervical Cancer: Clinical Trials

9 trials for Stage IA Cervical Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 active not recruiting, 1 terminated, 1 unknown. 3 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Unknown 1, Withdrawn 1
Phase 22Completed 2
Early Phase 11Active not recruiting 1
Phase 31Terminated 1

Follow Stage IA Cervical Cancer: new trials by email Literature Review of Stage IA Cervical Cancer trials Research Report on Stage IA Cervical Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer
Fludeoxyglucose F-18, Gadobutrol, Magnetic Resonance Imaging - Stage IA Cervical Cancer, Stage IA1 Cervical Cancer
Early Phase 1Active not recruitingM.D. Anderson Cancer Center252018-09-072026-05-20
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer
Not applicableCompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University402015-08-012025-04-29
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
Quality-of-Life Assessment, Questionnaire Administration, Study of High Risk Factors - Lymphedema, Stage IA Cervical Cancer
Not applicableUnknownGynecologic Oncology Group10552012-06-012017-05-08
Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer
behavioral, psychological or informational intervention - Ovarian Sarcoma, Ovarian Stromal Cancer
Phase 2CompletedOhio State University Comprehensive Cancer Center1002010-10-012018-05-30
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Medical Chart Review, Questionnaire Administration - Recurrent Cervical Carcinoma, Recurrent Uterine Corpus Carcinoma
CompletedGynecologic Oncology Group7782010-07-012018-04-12
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
Management of Therapy Complications, Quality-of-Life Assessment - Lymphedema, Stage 0 Cervical Cancer
Phase 3TerminatedGynecologic Oncology Group22007-12-012021-06-23
EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer
EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma
Phase 2CompletedNational Cancer Institute (NCI)602005-02-012013-01-16
Collecting Tumor Samples From Patients With Gynecological Tumors
Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor
CompletedGynecologic Oncology Group2751992-06-012016-10-28
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
colposcopy, cervical Papanicolaou test, screening method - Cervical Intraepithelial Neoplasia Grade 1, Cervical Intraepithelial Neoplasia Grade 2
Not applicableWithdrawnNorthwestern University2012-06-11

Narrower conditions

Uterine Cervical Neoplasms (9)  ·  Vulvar Neoplasms (5)  ·  Vaginal Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Endometrial Neoplasms (2)  ·  Fallopian Tube Neoplasms (2)  ·  Gestational Trophoblastic Disease (2)  ·  Lymphedema (2)  ·  Ovarian Neoplasms (2)  ·  Uterine Cervical Dysplasia (2)  ·  Brenner Tumor (1)  ·  Melanoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasms (1)

Broader conditions

Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Genital Diseases (9)  ·  Genital Diseases, Female (9)  ·  Genital Neoplasms, Female (9)  ·  Neoplasms by Site (9)  ·  Urogenital Diseases (9)  ·  Urogenital Neoplasms (9)  ·  Uterine Cervical Diseases (9)  ·  Uterine Diseases (9)  ·  Uterine Neoplasms (9)  ·  Neoplasms (8)  ·  Vulvar Diseases (5)  ·  Adnexal Diseases (4)  ·  Endocrine Gland Neoplasms (4)

Interventions

Colposcopy (1)  ·  Fluorodeoxyglucose F18 (1)  ·  High-Throughput Screening Assays (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Vaginal Smears (1)  ·  gadobutrol (1)

Sponsors

Gynecologic Oncology Group (4)  ·  M.D. Anderson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)  ·  Northwestern University (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (8)

Top investigators

Amy Halverson (1)  ·  Andrea Barsevick, PhD (1)  ·  Christina Chu (1)  ·  Kristen M. Carpenter, Ph.D (1)  ·  Levi Downs (1)  ·  Michael Cibull (1)  ·  Richard Barakat (1)  ·  Sanaz Javadi (1)  ·  Sandra Brooks (1)

Results publications

PMID 25937529, PMID 40082377

NIH funding

U10CA101165 (3), P30CA016672 (1), R21CA099346 (1), R21CA149675 (1), U10CA180868 (1), UG1CA189867 (1)